Grafa News and Videos — Page 41

Tiziana Life Sciences (NASDAQ:TLSA) submitted a request to the U.S. Food and Drug Administration for Orphan Drug Designation for intranasal foralumab as a potential treatment for multiple system atrophy (MSA).

Kailera Therapeutics (NASDAQ:KLRA) announced completion of enrollment across three global Phase 3 trials evaluating investigational once-weekly ribupatide injection in people with obesity or overweight.

Jade Biosciences (NASDAQ:JBIO) reported preclinical results for JADE301, an investigational antibody targeting dermatomyositis, at the European Academy of Dermatology and Venereology Congress in Vienna.

Connect Biopharma (NASDAQ:CNTB) reported preliminary Phase 2 results showing that investigational rademikibart reduced treatment failure in adults with acute chronic obstructive pulmonary disease (COPD) exacerbations and type 2 inflammation.

NRx Pharmaceuticals (NASDAQ:NRXP) announced that its subsidiary NRx Defense Systems received an initial DARPA prime contract worth $11,177,757.27 to evaluate a treatment approach for major depressive disorder.

Atara Biotherapeutics (NASDAQ:ATRA) announced that partner Pierre Fabre Pharmaceuticals resubmitted the Biologics License Application (BLA) for tabelecleucel to the U.S. Food and Drug Administration for treatment of relapsed or refractory EBV-positive post-transplant lymphoproliferative disease.

Cerenome (NASDAQ:CNSY) reported unaudited third-quarter 2026 gross payer billings of $1.55 million from 222 tests performed by its wholly owned CNSide Diagnostics subsidiary.

KIDZ AI (NASDAQ:KIDZ) submitted a procurement inquiry to Tesla for an initial 500 Robotaxis as part of a preliminary plan to explore an autonomous vehicle fleet strategy.

RedCloud (NASDAQ:RCT) reported revenue of $24 million for the six months ended June 30, 2026, an increase of 34% year over year, as total trading volume increased to $1.56 billion.

Ten-League International Holdings (NASDAQ:TLIH) reported unaudited first-half 2026 revenue of S$33.1 million for the six months ended June 30, 2026, with revenue declining as equipment and parts sales decreased.